Portugal’s score in Policy Context is close to the average. This is a result of Portugal having a relatively strong asthma strategy as well as having severe asthma guidelines, while weak tobacco control laws bring Portugal’s score down. Portugal is amongst the lowest scoring in terms of Access and Care Coverage, attributable to limited access to some treatments, especially biologics, FeNO-based diagnostics and digital therapeutics, though high levels of access to inflammatory phenotyping-based diagnostics and specialist care, as well as unmet needs below the average, bring Portugal’s score up. Portugal scores within the bottom third of countries in the Disease Burden category, with one of the highest estimated societal costs of asthma and percentage of DALYs attributable to asthma. However, Portugal displays a rate of deaths associated with asthma that is below the average.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Portugal
Provides further insights into how Portugal scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
Information about the health impact of severe asthma and severe asthma comorbidities
Factors impacting prevention, management, and exacerbations of severe asthma
Aggregate score across the 5 categories.
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall